Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
出版年份 2016 全文链接
标题
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
作者
关键词
DNA damage, DNA topoisomerase I, NSC 743400, Indenoisoquinolines, H2AX protein, Hair follicle
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 78, Issue 1, Pages 73-81
出版商
Springer Nature
发表日期
2016-05-11
DOI
10.1007/s00280-016-2998-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs
- (2015) Miguel Muzzio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen
- (2014) Nicola Silvestris et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer
- (2014) Joachim von Pawel et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Biological Evaluation of New Carbohydrate-Substituted Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan (LMP776)
- (2014) Daniel E. Beck et al. JOURNAL OF MEDICINAL CHEMISTRY
- Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer
- (2014) Chen Shao et al. PLoS One
- Identification, Synthesis, and Biological Evaluation of Metabolites of the Experimental Cancer Treatment Drugs Indotecan (LMP400) and Indimitecan (LMP776) and Investigation of Isomerically Hydroxylated Indenoisoquinoline Analogues as Topoisomerase I Poisons
- (2012) Maris A. Cinelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues
- (2012) Thomas D. Pfister et al. PLoS One
- Monitoring Drug-Induced H2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells
- (2010) L. H. Wang et al. CLINICAL CANCER RESEARCH
- Development of a Validated Immunofluorescence Assay for H2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity
- (2010) R. J. Kinders et al. CLINICAL CANCER RESEARCH
- A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)
- (2010) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
- Liquid chromatography–tandem mass spectrometric assay for the quantitation in human plasma of the novel indenoisoquinoline topoisomerase I inhibitors, NSC 743400 and NSC 725776
- (2010) Julianne L. Holleran et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The Use of Gamma-H2AX as a Biodosimeter for Total-Body Radiation Exposure in Non-Human Primates
- (2010) Christophe E. Redon et al. PLoS One
- Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy
- (2009) Ioannis Kostopoulos et al. BMC CANCER
- Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
- (2009) T. D. Pfister et al. MOLECULAR CANCER THERAPEUTICS
- Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
- (2008) Michael S. Braun et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now